1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. GCC Non-Invasive Neurostimulation Devices Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. GCC Non-Invasive Neurostimulation Devices Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. GCC Non-Invasive Neurostimulation Devices Market Regional Analysis
6.2 GCC Non-Invasive Neurostimulation Devices Market Revenue 2022-2033 (US$ Million)
6.3 GCC Non-Invasive Neurostimulation Devices Market Forecast Analysis
7. GCC Non-Invasive Neurostimulation Devices Market Analysis – by Product Type
7.1 Transcranial Magnetic Stimulation Devices
- 7.1.1 Overview
- 7.1.2 Transcranial Magnetic Stimulation Devices: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.2 Transcranial Direct Current Stimulation Devices
- 7.2.1 Overview
- 7.2.2 Transcranial Direct Current Stimulation Devices: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.3 Transcranial Ultrasound Stimulation Devices
- 7.3.1 Overview
- 7.3.2 Transcranial Ultrasound Stimulation Devices: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
7.4 Other Product Types
- 7.4.1 Overview
- 7.4.2 Other Product Types: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8. GCC Non-Invasive Neurostimulation Devices Market Analysis – by Application
8.1 Pain & Sensory Modulation
- 8.1.1 Overview
- 8.1.2 Pain & Sensory Modulation: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.2 Functional Disorders
- 8.2.1 Overview
- 8.2.2 Functional Disorders: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.3 Cognitive & Behavioral Regulation
- 8.3.1 Overview
- 8.3.2 Cognitive & Behavioral Regulation: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
8.4 Other Applications
- 8.4.1 Overview
- 8.4.2 Other Applications: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9. GCC Non-Invasive Neurostimulation Devices Market Analysis – by End User
9.1 Hospitals
- 9.1.1 Overview
- 9.1.2 Hospitals: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.2 Specialty Clinics
- 9.2.1 Overview
- 9.2.2 Specialty Clinics: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
9.4 Other End Users
- 9.4.1 Overview
- 9.4.2 Other End Users: GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast, 2022-2033 (US$ Million)
10. GCC Non-Invasive Neurostimulation Devices Market – GCC Analysis
10.1 Overview
10.2 GCC
- 10.2.1 GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Key
Country, 2026 and 2033 (%)
- 10.2.1.1 GCC Non-Invasive Neurostimulation Devices Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 UAE:
GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.1.1 UAE: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.1.2 UAE: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.1.3 UAE: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.2 Bahrain:
GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.2.1 Bahrain: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.2.2 Bahrain: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.2.3 Bahrain: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.3 Saudi Arabia:
GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.3.1 Saudi Arabia: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.3.2 Saudi Arabia: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.3.3 Saudi Arabia: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.4 Oman:
GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.4.1 Oman: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.4.2 Oman: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.4.3 Oman: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.5 Qatar:
GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.5.1 Qatar: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.5.2 Qatar: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.5.3 Qatar: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by End User
- 10.2.1.6 Kuwait:
GCC Non-Invasive Neurostimulation Devices Market – Revenue and Forecast to 2033 (US$ Million)
- 10.2.1.6.1 Kuwait: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Product Type
- 10.2.1.6.2 Kuwait: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by Application
- 10.2.1.6.3 Kuwait: GCC Non-Invasive Neurostimulation Devices Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 ONWARD Medical N.V.
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 eNeura Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Neuronetics
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BrainsWay Ltd.
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Soterix Medical Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Flow Neuroscience
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Magstim
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nexstim
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Neurosoft
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Remed
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations